Peripartum Cardiomyopathy

https://doi.org/10.4081/monaldi.2008.431

Authors

  • Riccardo Raddino | office@pagepress.org Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia, Italy.
  • Ivano Bonadei Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia, Italy.
  • Melissa Teli Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia, Italy.
  • Federica Chieppa Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia, Italy.
  • Giorgio Caretta Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia, Italy.
  • Debora Robba Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia, Italy.
  • Gregoriana Zanini Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia, Italy.
  • Enrico Vizzardi Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia, Italy.
  • Livio Dei Cas Sezione di Malattie Cardiovascolari, Dipartimento di Medicina Sperimentale Applicata, Università degli Studi di Brescia, Italy.

Abstract

which left ventricular dysfunction and symptoms of heart failure occur in the peripartum period in previously healthy women. Incidence of PPCM ranges from 1 in 1300 to 1 in 15,000 pregnancies. The etiology of PPCM is unknown, but viral, autoimmune, and idiopathic causes may contribute. The diagnostic criteria are onset of heart failure in the last month of pregnancy or in the first 5 months postpartum, absence of determinable cause for cardiac failure, and absence of a demonstrable heart disease before the last month of pregnancy. Risk factors for PPCM include advanced maternal age, multiparity, African race, twinning, gestational hypertension, and long-term tocolysis. The clinical presentation of patients with PPCM is similar to that of patients with dilated cardiomyopathy. Echocardiography is central to diagnosis. Early diagnosis and initiation of treatment are essential to optimize pregnancy outcome. Treatment is similar to medical therapy for other forms of dilated cardiomyopathy. About half the patients of PPCM recover without complications. The prognosis is poor in patients with persistent cardiomyopathy. Persistence of disease after 6 months indicates irreversible cardiomyopathy and portends worse survival.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2016-01-26
Info
Issue
Section
Reviews
Keywords:
peripartum cardiomyopathy, left ventricular disfunction, heart failure
Statistics
  • Abstract views: 516

  • PDF: 358
How to Cite
Raddino, Riccardo, Ivano Bonadei, Melissa Teli, Federica Chieppa, Giorgio Caretta, Debora Robba, Gregoriana Zanini, Enrico Vizzardi, and Livio Dei Cas. 2016. “Peripartum Cardiomyopathy”. Monaldi Archives for Chest Disease 70 (1). https://doi.org/10.4081/monaldi.2008.431.

Most read articles by the same author(s)

1 2 > >>